Stocks and Investing
Stocks and Investing
Mon, May 2, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mohit Bansal Maintained (ABBV) at Buy with Increased Target to $200 on, May 2nd, 2022
Mohit Bansal of Wells Fargo, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $165 to $200 on, May 2nd, 2022.
Mohit has made no other calls on ABBV in the last 4 months.
There are 15 other peers that have a rating on ABBV. Out of the 15 peers that are also analyzing ABBV, 5 agree with Mohit's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $156 on, Friday, April 22nd, 2022
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $140 on, Tuesday, April 12th, 2022
- Carter Gould of "Barclays" Maintained at Hold with Increased Target to $174 on, Tuesday, April 12th, 2022
- Luisa Hector of "Berenberg" Reiterated at Hold and Held Target at $115 on, Monday, February 28th, 2022
- Colin Bristow of "UBS" Downgraded from Strong Buy to Hold and Increased Target to $147 on, Monday, February 28th, 2022
These are the ratings of the 10 analyists that currently disagree with Mohit
- Tim Anderson of "Wolfe Research" Maintained at Buy with Decreased Target to $170 on, Sunday, May 1st, 2022
- Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $160 on, Friday, April 29th, 2022
- Gary Nachman of "BMO Capital" Maintained at Buy with Increased Target to $174 on, Monday, April 25th, 2022
- Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $180 on, Thursday, April 14th, 2022
- Terence Flynn of "Morgan Stanley" Maintained at Buy with Increased Target to $192 on, Wednesday, April 6th, 2022
- Andrew Baum of "Citigroup" Reiterated at Strong Buy with Increased Target to $170 on, Tuesday, March 1st, 2022
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $166 on, Friday, February 4th, 2022
- Christopher Raymond of "Piper Sandler" Reiterated at Buy and Held Target at $160 on, Tuesday, January 18th, 2022
- Charles Pitman of "Redburn Partners" Initiated at Strong Buy on, Thursday, January 13th, 2022
- Aaron Gal of "Bernstein" Maintained at Buy with Increased Target to $155 on, Monday, January 3rd, 2022
Contributing Sources